Showing results (241-250 of 365) with videos related to
Sort By:
Pageof 37
Epigenetics|January 21, 2016
Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patientsEfterpi Kostareli, Thomas Hielscher, Manuela Zucknick, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.Nature Immunology|August 8, 2017
Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissuesMichael Delacher, Charles D Imbusch, Dieter Weichenhan, et al.Plos Computational Biology|August 6, 2016
Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer CellsRuth Merkle, Bernhard Steiert, Florian Salopiata, et al.British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.Nucleic Acids Research|October 31, 2021
ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibitionAli Bakr, Joschka Hey, Gianluca Sigismondo, et al.Nature Communications|December 23, 2025
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancerMigle Mikutenaite, Evdoxia Karadoulama, Francesco Favero, et al.Nature Immunology|November 17, 2017
Corrigendum: Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissuesMichael Delacher, Charles D Imbusch, Dieter Weichenhan, et al.Blood|March 19, 2005
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapySusan P Whitman, Shujun Liu, Tamara Vukosavljevic, et al.Human Molecular Genetics|November 28, 2013
Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancerChristine Kuhmann, Carmen Li, Matthias Kloor, et al.Pageof 37